Ascom Holding AG reported 2025 net revenue of CHF 292.1 million, a 1.9% increase from the prior year. The Swiss healthcare technology firm saw its EBITDA margin surge to roughly 11.5%-12%, a major improvement from 7.4% in 2024. Incoming orders also rose, reaching CHF 311.1 million for the year.

Profitability was driven by a major U.S. order delivered in December and steady gains across all regions. The USA and Canada division posted the strongest revenue growth at 7.3%, while Europe and other territories also expanded. Management credited operational improvements for the stronger bottom line and a net cash position that climbed to CHF 29.6 million.

Looking ahead, Ascom expects group profit to reach a low double-digit million figure in Swiss francs for 2025. The company’s order backlog finished the year at CHF 310.7 million, providing solid visibility. Investors will watch for the company to sustain this momentum in 2026.